Steven Levine, MD: Could you talk a little bit about some of the barriers that exist and how they can possibly be overcome? Patricia Ares-Romero, MD, FASAM: A person of the greatest challenges early on when the Fda authorised intranasal esketamine was obtaining the prior authorization. It was obtaining approved […]
Sunday, Nov 1, 2026
Breaking News